Market revenue in 2024 | USD 304.7 million |
Market revenue in 2030 | USD 635.6 million |
Growth rate | 13.1% (CAGR from 2025 to 2030) |
Largest segment | Creams |
Fastest growing segment | Silicon Sheets |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Creams, Gels, Silicon Sheets |
Key market players worldwide | Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Newmedical, Molnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, SCAR |
Creams was the largest segment with a revenue share of 40.4% in 2024. Horizon Databook has segmented the China topical scar treatment market based on creams, gels, silicon sheets covering the revenue growth of each sub-segment from 2018 to 2030.
The topical scar treatment market in China is growing rapidly, driven largely by a rise in acne-related scarring. A September 2022 study in Dermatology and Venereology highlighted that approximately 7.1% of Chinese adolescents suffer from acne scars, with acne typically emerging after the age of 13.
Among affected individuals, multiple types of atrophic scars may appear, while hypertrophic scar and keloids are more prevalent in darker-skinned individuals, particularly on the trunk and jawline. This increasing prevalence of acne scars has heightened demand for effective topical treatments, including siliconebased gels and scar creams.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account